What is the purpose of this trial?
The aims of this project are to determine if dietary supplementation with NOPE-EGCG (PhosphoLeantm, 30mg NOPE+20mg EGCG per capsule) can:
- rescue striatal function,
- increase adherence to a diet,
- reduce weight-gain after a diet,
- improve performance on impulsivity, go/no-go tasks, and negative outcome learning, and
- shift fat and sweet preference in overweight/obese human subjects in a double-blind cross-over design.
Ages: 18 - 45 years
National Cancer Institute
Start Date: 11/11/2013
End Date: 10/15/2017
Last Updated: 02/22/2018
Study HIC#: 1308012537